Bionoid Pharma Stock Analysis
| BINP Stock | USD 0.11 0.09 45.00% |
Bionoid Pharma is overvalued with Real Value of 0.11 and Hype Value of 0.11. The main objective of Bionoid Pharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bionoid Pharma is worth, separate from its market price. There are two main types of Bionoid Pharma's stock analysis: fundamental analysis and technical analysis.
The Bionoid Pharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Bionoid |
Bionoid Pink Sheet Analysis Notes
The company recorded a loss per share of 46.27. Bionoid Pharma had not issued any dividends in recent years. The entity had 1:2500 split on the 25th of February 2020. Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.The quote for Bionoid Pharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bionoid Pharma please contact the company at 800 784 7641 or go to https://bionoidpharma.com.Bionoid Pharma Investment Alerts
| Bionoid Pharma generated a negative expected return over the last 90 days | |
| Bionoid Pharma has high historical volatility and very poor performance | |
| Bionoid Pharma has some characteristics of a very speculative penny stock | |
| Bionoid Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Bionoid Pharma currently holds 64.5 K in liabilities. Bionoid Pharma has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bionoid Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Bionoid Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bionoid Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bionoid to invest in growth at high rates of return. When we think about Bionoid Pharma's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 92.26 K. Net Loss for the year was (1.62 M) with profit before overhead, payroll, taxes, and interest of 47.48 K. | |
| Bionoid Pharma currently holds about 127 in cash with (357.62 K) of positive cash flow from operations. |
Bionoid Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bionoid Pharma's market, we take the total number of its shares issued and multiply it by Bionoid Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Bionoid Pharma shows the Mean Deviation of 5.39, standard deviation of 13.28, and Risk Adjusted Performance of 0.0503. Bionoid Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bionoid Pharma Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bionoid Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bionoid Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bionoid Pharma Predictive Daily Indicators
Bionoid Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bionoid Pharma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.55 | |||
| Day Median Price | 0.11 | |||
| Day Typical Price | 0.11 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.09) |
Bionoid Pharma Forecast Models
Bionoid Pharma's time-series forecasting models are one of many Bionoid Pharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bionoid Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bionoid Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bionoid Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bionoid shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bionoid Pharma. By using and applying Bionoid Pink Sheet analysis, traders can create a robust methodology for identifying Bionoid entry and exit points for their positions.
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bionoid Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.